Sign In
Buy HCA
$390.74
-15.85 (-3.90%)
At Close: Jul 13, 2026
Is the Options Market Predicting a Spike in HCA Healthcare Stock?
01:21pm, Wednesday, 08'th Jul 2026
Investors need to pay close attention to HCA stock based on the movements in the options market lately.
This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
08:24am, Wednesday, 08'th Jul 2026
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Top 50 High-Quality Dividend Growth Stocks For July 2026
07:42am, Wednesday, 08'th Jul 2026
I track a curated universe of 50 high-quality dividend growth stocks to identify opportune entry points based on valuation and future return potential. Year-to-date through June, the investable univer
HCA Healthcare's Fall Shouldn't Be Construed As Failing Health
10:20pm, Tuesday, 07'th Jul 2026
HCA Healthcare remains a soft 'buy' despite recent underperformance, with fundamentals improving and shares attractively priced on an absolute basis. HCA's revenue and profitability continue to grow,
Your Hospital’s HR Won’t Tell You This: Nurses Can Legally Shield $49,000 a Year by Stacking a 403(b) and a 457(b)
05:13pm, Tuesday, 07'th Jul 2026
Your hospital's benefits packet lists a 403(b), and it may also quietly list a 457(b) on a separate page. Human resources rarely explains what happens when a nurse funds both: the IRS treats them as s
Can HCA's Capacity Expansion Strategy Fuel Its Long-Term Growth?
01:25pm, Tuesday, 07'th Jul 2026
HCA is expanding hospitals, ERs and outpatient sites while investing billions in new capacity to support future healthcare demand and long-term growth.
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
10:30am, Monday, 06'th Jul 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Can HCA's Gene Therapy Milestone Drive Long-Term Growth?
02:06pm, Wednesday, 01'st Jul 2026
HCA Healthcare highlights promising pediatric CRISPR gene therapy results as expanding specialty care and research investments support its long-term growth strategy.
HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children
08:30am, Monday, 29'th Jun 2026
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced new research published in The New England Journal of Medicine (NEJ
HCA Healthcare (HCA) is a Top-Ranked Growth Stock: Should You Buy?
10:46am, Friday, 26'th Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term
10:31am, Thursday, 25'th Jun 2026
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
10:41am, Wednesday, 24'th Jun 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Healthcare Added 35,200 Jobs—3 Stocks Positioned to Benefit
09:50am, Monday, 15'th Jun 2026
The May Jobs report told a familiar story for investors in healthcare stocks. The sector added 35,200 positions last month, led by ambulatory health services at 25,700 and hospitals at 6,000.
Is HCA Undervalued? DCF Says Worth $765
07:03am, Wednesday, 10'th Jun 2026
On June 10, 2026, we present a detailed DCF analysis for HCA Healthcare Inc (HCA), a company currently facing a challenging price performance context with a yea
Mission Bio and Human Cell Atlas Collaborate to Expand Access to Single-Cell Multiomics Ahead of HCA 2026 Meeting
09:00am, Tuesday, 09'th Jun 2026
SAN FRANCISCO--(BUSINESS WIRE)--Mission Bio, the leader in single-cell multiomics solutions, today announced a collaboration with the Human Cell Atlas (HCA), a global consortium working to create comp
